Can CBD Cure Anxiety Disorders?
Anxiety disorder is a mental health condition that involves a feeling of insecurity and fear. People having serious anxiety symptoms suffer from panic attacks, intense situations where they feel insecure, and fear or terror....
Read More
Seven Emerging Job Opportunities in Weed
Got a bad case of the Mondays? Maybe a career shift is in order… Here are some emerging job opportunities in weed.
Read More
5 Qualities a Dispensary Budtender Needs to Have
As world markets continue to be affected by the Coronavirus (COVID-19), corporations in all...
Read More
FEATURED NEWS
Sorry, no posts were found.
LATEST STOCK NEWS
Experienced traders all have their horror stories about how they tried to fight the market or how they placed a bad bet on a hunch. On the other hand, those… Jonathan Rider, veteran of Monster.com, is Chief Information OfficerAdvances corporate emphasis on systems IT, data management and CRM. The company announced the completion of an interim statistical assessment of its Phase 2 trial of Oral KORSUVA™ (CR845/difelikefalin) for the treatment of pruritus.Important Questions You Should Always Ask About Weed Stocks Before Buying It
MariMed Expands Executive Team with CIO Addition
Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVA™ in Chronic Kidney Disease Patients with Pruritus after Completion of Interim Statistical Assessment
GET LISTED
